Home › Kanser sa Prostate › Texas › Austin
Pag-aaral pangklinika para sa Kanser sa Prostate sa Austin, TX
14 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Austin (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
WATER IV PCa (AS Sub-study)
Nagre-recruit
- Midtown Urology, Austin
- Urology Austin, Austin
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Nagre-recruitPhase 4
- Urology Austin, Austin
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Nagre-recruitPhase 1/2
- NEXT Oncology, Austin
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 135, Austin
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Nagre-recruitPhase 3
- Texas Oncology - Central/South Texas ( Site 8003), Austin
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Nagre-recruitPhase 3
- Research Site, Austin
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Nagre-recruitPhase 3
- Urology Austin, Lakeway · 16 mi ang layo
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Nagre-recruitPhase 3
- Research Site, Austin
- Research Site, Austin
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Nagre-recruit
- Urology Austin, Austin
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Nagre-recruitPhase 3
- Urology Austin, PLLC - Research Department, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Austin, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, Austin, TX 78758
Sample Collection for Ongoing Research and Product Evaluation Study
Nagre-recruitObservasyonal na pag-aaral
- Natera, Inc., Austin
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY101 pag-aaral
- Houston, TX73 pag-aaral
- Los Angeles, CA64 pag-aaral
- Boston, MA56 pag-aaral
- Seattle, WA45 pag-aaral
- St. Louis, MO45 pag-aaral
- Chicago, IL45 pag-aaral
- Baltimore, MD45 pag-aaral
- San Francisco, CA44 pag-aaral
- Philadelphia, PA41 pag-aaral
- Nashville, TN40 pag-aaral
- Washington, DC39 pag-aaral
Iba pang pag-aaral sa Austin
- Non-Small Cell Lung Cancer29 pag-aaral
- Kanser (lahat ng uri)22 pag-aaral
- Obesity22 pag-aaral
- Overweight19 pag-aaral
- Metastatic Cancer18 pag-aaral
- Colorectal Cancer17 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Pagkabigo ng Puso17 pag-aaral
- Kanser ng Endometrium15 pag-aaral
- Kanser sa Suso15 pag-aaral
- Type 2 Diabetes14 pag-aaral
- Steatotic Liver Disease13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.